- Report
- September 2026
- 196 Pages
Global
From €3262EUR$3,545USD£2,724GBP
€3624EUR$3,939USD£3,027GBP
- Report
- January 2026
- 185 Pages
Global
From €4141EUR$4,500USD£3,458GBP
- Report
- July 2026
- 125 Pages
Global
From €3500EUR$4,075USD£3,025GBP
- Report
- October 2026
- 407 Pages
Global
From €6436EUR$6,995USD£5,376GBP
- Report
- October 2026
- 336 Pages
Global
From €4416EUR$4,799USD£3,688GBP
- Report
- July 2026
- 732 Pages
Global
From €4555EUR$4,950USD£3,804GBP
- Report
- May 2026
- 468 Pages
Global
From €6579EUR$7,150USD£5,495GBP
- Report
- March 2026
- 150 Pages
Global
From €5475EUR$5,950USD£4,573GBP
- Report
- June 2026
- 200 Pages
Global
From €2751EUR$2,990USD£2,298GBP
- Report
- January 2026
- 326 Pages
Global
From €4141EUR$4,500USD£3,458GBP
- Report
- September 2026
- 120 Pages
Global
From €5475EUR$5,950USD£4,573GBP
- Report
- May 2026
- 150 Pages
Global
From €5475EUR$5,950USD£4,573GBP
- Report
- April 2026
- 146 Pages
Global
From €3680EUR$3,999USD£3,073GBP
- Report
- April 2026
- 137 Pages
Global
From €3680EUR$3,999USD£3,073GBP
- Report
- April 2026
- 141 Pages
Global
From €3680EUR$3,999USD£3,073GBP
- Report
- May 2026
- 150 Pages
Global
From €5475EUR$5,950USD£4,573GBP
- Report
- April 2026
- 120 Pages
Global
From €5475EUR$5,950USD£4,573GBP
- Report
- May 2026
- 188 Pages
Global
From €4141EUR$4,500USD£3,458GBP
- Report
- November 2026
- 278 Pages
Global
From €5383EUR$5,850USD£4,496GBP
- Report
- May 2026
- 185 Pages
Global
From €4141EUR$4,500USD£3,458GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more